Study of the apheresis therapy.

Study of the apheresis therapy. - The effects of apheresis therapy on renal impairment: APHEREIT Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000003227

Enrollment

Registered

2010-02-23

Start date

2010-02-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diseases on apheresis therapy including renal diseases.

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The patients on apheresis who agreed with this observational study.

Exclusion criteria

Exclusion criteria: Exclusion criteria: Judged as unsuitable by physician.

Design outcomes

Primary

Measure	Time frame
Clinical improvement, markers of inflammation and oxidative stress, pathological factors including cytokines, proteinuria, renal function, and prognosis	—

Countries

Japan

Contacts

Public ContactYukiko Hasuike

Hyogo College of Medicine Department of Internal Medicine, Division of Kidney and Dialysis

cherry39@hyo-med.ac.jp0798-45-6521

Outcome results